Gabelli Downgrades Diebold (DBD) to Hold following Q3; Risks Ahead

Go back to Gabelli Downgrades Diebold (DBD) to Hold following Q3; Risks Ahead

Diebold, Inc. (DBD) Misses Q3 EPS by 11c; Trims FY12 Outlook

October 25, 2012 8:26 AM EDT

Diebold, Inc. (NYSE: DBD) reported Q3 EPS of $0.39, $0.11 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $709.92 million versus the consensus estimate of $735 million.

Diebold, Inc. sees FY2012 EPS of $2.25-2.30, versus prior guidance of $2.50-2.60 and the consensus of $2.30.... More